Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review
Prostate cancer is a disease of older adults that has undergone a significant therapeutic paradigm shift in the last decade with the emergence of novel androgen receptor pathway inhibitors (ARPis). One of the more commonly used ARPis is enzalutamide. This drug, along with darolutamide and apalutamid...
Main Authors: | Nabiel Mir, Olivia Burke, Samuel Yates, Tanujaa Rajasekaran, Johan Chan, Russell Szmulewitz, Ravindran Kanesvaran |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-01-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359221149887 |
Similar Items
-
Identification of Comprehensive Geriatric Assessment Based Risk Factors for Malnutrition in Elderly Asian Cancer Patients.
by: Tira Tan, et al.
Published: (2016-01-01) -
Geriatric Oncology as an Unmet Workforce Training Need in the United Kingdom—A Narrative Review by the British Oncology Network for Undergraduate Societies (BONUS) and the International Society of Geriatric Oncology (SIOG) UK Country Group
by: Emma G. Khoury, et al.
Published: (2023-09-01) -
SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly
by: Matti Aapro
Published: (2011-10-01) -
Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
by: Steven Kregel, et al.
Published: (2013-01-01) -
Summary of the Updated American Geriatrics Society/British Geriatrics Society Clinical Practice Guideline for Prevention of Falls in Older Persons
by: Kenny, R, et al.
Published: (2011)